"Minocycline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
| Descriptor ID |
D008911
|
| MeSH Number(s) |
D02.455.426.559.847.562.900.550 D04.615.562.900.550
|
| Concept/Terms |
Minocycline Hydrochloride- Minocycline Hydrochloride
- Hydrochloride, Minocycline
- Minocycline Monohydrochloride
- Monohydrochloride, Minocycline
|
Below are MeSH descriptors whose meaning is more general than "Minocycline".
Below are MeSH descriptors whose meaning is more specific than "Minocycline".
This graph shows the total number of publications written about "Minocycline" by people in this website by year, and whether "Minocycline" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 2000 | 1 | 0 | 1 |
| 2002 | 3 | 1 | 4 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2015 | 1 | 2 | 3 |
| 2017 | 4 | 0 | 4 |
| 2018 | 1 | 1 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 0 | 1 | 1 |
| 2022 | 2 | 0 | 2 |
| 2026 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Minocycline" by people in Profiles.
-
Antibacterial Envelope Is Associated With?Low Infection Rates After Implantable Cardioverter-Defibrillator and?Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol. 2017 10; 3(10):1158-1167.
-
Prevention of transmission of multidrug-resistant organisms during catheter exchange using antimicrobial catheters. Antimicrob Agents Chemother. 2014 Sep; 58(9):5291-6.
-
Prevention of biofilm colonization by Gram-negative bacteria on minocycline-rifampin-impregnated catheters sequentially coated with chlorhexidine. Antimicrob Agents Chemother. 2014; 58(2):1179-82.
-
Chelator-based catheter lock solutions in eradicating organisms in biofilm. Antimicrob Agents Chemother. 2013 Jan; 57(1):586-8.
-
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling. Pain. 2010 Sep; 150(3):550-560.
-
The efficacy of catheters coated with minocycline and rifampin in the prevention of catheter-related bacteremia in cancer patients receiving high-dose interleukin-2. Int J Infect Dis. 2010 Jul; 14(7):e548-52.
-
Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol. 2007 May; 28(5):599-601.
-
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother. 2007 May; 51(5):1656-60.
-
Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother. 2007 Jan; 51(1):78-83.
-
Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model. Cancer Lett. 2006 Jul 18; 238(2):197-201.